Enyinnaya Ukaegbu

Dr. Enyinnaya Ukaegbu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2024 in Narra X
Verified
Journal Article
Open access
PDF file
SMShuaibu S. Musa
Shuaibu S. Musa
AMAdamu Ibrahim Muhammad
Adamu Ibrahim Muhammad
MOMolly U. Ogbodum
Molly U. Ogbodum
UHUsman A. Haruna
Usman A. Haruna
AGAhmed A. Gololo
Ahmed A. Gololo
DIDon Eliseo Lucero-Prisno III
Don Eliseo Lucero-Prisno III
The Alma-Ata Declaration of 1978 defined primary healthcare as a critical way to obtain universal health care and 'health for all.' In Nigeria, the National Health Policy (NHP) and the subsequent formation of the Primary Health Care (PHC) system aim to modernize healthcare delivery, at the grassroots level. In recent decades, however, the status of primary healthcare in Nigeria, particularly in the northeastern region, has significantly deteriorated, further posing significant threats to health equity and universal access to healthcare. Armed conflicts, humanitarian crises, insufficient finance, inadequate infrastructure, and labor shortages have negatively impacted the region's PHC facilities. This article discusses the poor state of primary healthcare in northeastern Nigeria and its implications for achieving universal health coverage in the region. In addition, the article elaborates on the historical context, highlights the difficulties and challenges in the development of primary healthcare, and explores potential solutions to improve the system.

14 January 2025 in Medicina
Verified
Journal Article
Open access
PDF file
Enyinnaya UkaegbuEnyinnaya Ukaegbu
Enyinnaya Ukaegbu
TMTilektes Maulenkul
Tilektes Maulenkul
ASAntonio Sarria-Santamera
Antonio Sarria-Santamera
Background and Objectives: People living with HIV/AIDS have been impacted notably by the COVID-19 pandemic in diverse dimensions. Although some impacts of COVID-19 on PLHIV have been well documented, there is still insufficient research that captures the overall understanding of the implications of COVID-19 for the healthcare utilization among PLHIV. This review aims to evaluate the impact of COVID-19 on PLHIV, narrowing it down to women living with HIV/AIDS. Materials and Methods: An electronic database search of primary studies that obtained information from health facility data regarding PLHIV since 2020 was carried out according to the PRISMA statement. A combination of search terms, e.g., “COVID-19 pandemic”, “SARS-CoV-2”, “Health services utilization”, “People living with Human immunodeficiency virus”, was included. Results: There was an overall decline in the utilization of health services such as medical consultations, ART uptake, and viral load monitoring by PLHIV at primary health centers at the forefront of care delivery. However, the countries in the sub-Saharan African region showed a progressive service increase over the pandemic. There was a scarcity of research on the impact of COVID-19 on women populations living with HIV/AIDS. Other methods of healthcare delivery such as telemedicine and postage services were instrumental to the delivery of HIV care services. Conclusions: The COVID-19 pandemic reduced the overall uptake of healthcare services among PLHIV and women living with HIV/AIDS. There is a need to boost research and strengthen health emergency preparedness for PLHIV, particularly women living with HIV/AIDS, during pandemics and further harness and maximize the use of contemporary healthcare delivery methods other than the traditional ones.

31 August 2023 in Journal of the Korean Association of Oral and Maxillofacial Surgeons
Verified
Journal Article
Open access
PDF file
AAAdekunle Moses Adetayo
Adekunle Moses Adetayo
OYOlukayode Adebola Yusuf
Olukayode Adebola Yusuf
CIChika Precious Ibeh
Chika Precious Ibeh
Enyinnaya UkaegbuEnyinnaya Ukaegbu
Enyinnaya Ukaegbu
FOFadekemi Oginni
Fadekemi Oginni
MAModupe Olusola Adetayo
Modupe Olusola Adetayo
Adekunle Moses Adetayo, Olukayode Adebola Yusuf, Chika Precious Ibeh, Eyinnaya Ukaegbu, Fadekemi Oginni, Modupe Olusola Adetayo. JKAOMS 2023;49:223-7. https://doi.org/10.5125/jkaoms.2023.49.4.223

19 November 2025 in Electronic Journal of General Medicine
Verified
Journal Article
Closed access
AAAbdulafeez Katibi Abdulkadir
Abdulafeez Katibi Abdulkadir
AGArnur Gusmanov
Arnur Gusmanov
MMMuhammad Kabir Musa
Muhammad Kabir Musa
UHUsman Abubakar Haruna
Usman Abubakar Haruna
Enyinnaya UkaegbuEnyinnaya Ukaegbu
Enyinnaya Ukaegbu
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Background: Leukemia is the fifth leading cause of cancer mortality worldwide. Based on the rate of cellular division, leukemia is classified into acute or chronic myeloid or lymphoid types. Previous studies have highlighted rising leukemia cases in Kazakhstan; however, no study has described the epidemiology of leukemia and its subtypes. Methods: This retrospective cohort study uses the unified nationwide electronic healthcare system to characterize the epidemiology of leukemia and its subtypes in patients treated in any clinical setting in Kazakhstan from 2014 to 2019. The Chi-square test was used for categorical variables, the independent t-tests for continuous numeric variables between two groups, and ANOVA for comparing means across multiple groups. A cox proportional hazards regression model calculates crude and adjusted hazard ratios for all-cause mortality risk. Results: Of 9,561 patients, 4,783 (50.1%) were male and 4,778 (49.9%) were female. Median survival was 12 years (4,508 days). Mortality rates varied, with a slight increase in unspecified leukemia (C95) diagnoses in 2018-2019. Males (HR = 1.15, [95% CI: 1.07-1.23]), urban residents (HR = 1.52, [95% CI: 1.40-1.65]), and older individuals had higher mortality risks. Russians (HR = 1.42, [95% CI: 1.28-1.57]) and patients with hypertension (HR = 1.58, [95% CI: 1.53-1.64]) or chronic kidney disease (HR = 1.84, [95% CI: 1.60-2.10]) faced higher risk of death. Conclusion: Leukemia incidence and mortality in Kazakhstan are higher among males, urban residents, older individuals, and patients with comorbidities. These findings highlight the need for targeted healthcare policies and clinical management strategies to address disparities and improve outcomes in Kazakhstan.

4 November 2026 in Environmental Sciences Europe
Verified
Journal Article
Open access
PDF file
TOToheeb Olalekan Oladejo
Toheeb Olalekan Oladejo
AOAigerim Omirzakova
Aigerim Omirzakova
MAMary Awele Ashibuogwu
Mary Awele Ashibuogwu
PUPrecious Okeoghene Umukoro
Precious Okeoghene Umukoro
RARukayya Abdulsalam
Rukayya Abdulsalam
JAJoseph Almazan
Joseph Almazan
The Kyzylorda region of Kazakhstan is an example of climate-intensified aridification exacerbating the vulnerability of legacy environmental pollutants. The desiccation of the Aral Sea was primarily caused by the extensive diversion of the Syr Darya and Amu Darya rivers for irrigation. This narrative review synthesizes and contextualizes evidence on the major contaminant sources, climate-driven mobilization processes, human exposure pathways, and associated health outcomes in the region. The major anthropogenic inputs of heavy metals in the region include agricultural, industrial, and mining activities in the Syr Darya-Aral Sea system, with some contribution from naturally occurring geogenic sources. Climate-driven drying of water bodies and soils has increased pollutant concentrations, while enhanced mobilization via dust storms, surface water flow, and groundwater transport has expanded environmental dispersion. Human exposure occurs predominantly through the inhalation of contaminated dust and the consumption of contaminated water and food cultivated in affected soils. Regional observational studies suggest potential associations between environmental pollution and some adverse health outcomes, particularly in potentially vulnerable groups, but causal links to metals remain poorly established. The review also examines mitigation strategies and their potential application in the Kyzylorda region to reduce further climate-driven health impacts.